Schedule 13G ownership disclosure

Adagene Inc.

Ordinary shares, par value US$0.0001 per share · CUSIP: 005329107

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • WuXi PharmaTech Healthcare Fund I L.P.

    Shares: 4,978,628.00 · Class: 8.5%

  • WuXi AppTec Co., Ltd.

    Shares: 4,978,628.00 · Class: 8.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-013243
Form type
SCHEDULE 13G/A
Filer
Adagene Inc.
CIK
CIK 1818838
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub